Resumo

URQUIZO AYALA, Guillermo  e  HENAO SANJINES, Milenca Valentina. USO DE INHIBIDORES DE SGLT 2 EN PACIENTES CON NEFROPATÍA DIABÉTICA. Rev. Méd. La Paz [online]. 2023, vol.29, n.2, pp.77-79.  Epub 30-Dez-2023. ISSN 1726-8958.

Oral antidiabetic treatment has been a challenge in the management of diabetes mellitus in patients with some degree of chronic kidney disease due to the constant risks of hypoglycemia; however, glucose transporter SGLT2 inhibitors represent a new therapeutic approach to diabetes mellitus. Type 2, studies in experimental models of diabetes have shown thatthe induction of glycosuria reverses glucotoxicity, restores normoglycemia, and improves beta cell function and insulin sensitivity.

Palavras-chave : Oral antidiabetic; chronic kidney disease; hypoglycemia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )